A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

Women on Mounjaro may miss signs of pancreatitis. Learn the symptoms, risks, and what UK health authorities are doing to ...

The medicines regulator is investigating after hundreds of people have reported problems with their pancreas linked to taking ...

Investing.com - 诺和诺德公司 A/S (CSE: NOVOb )股价周一下跌超过2%，此前在芝加哥举行的美国糖尿病协会 ...

India approves Eli Lilly’s Mounjaro KwikPen, a once-weekly injection for type 2 diabetes and obesity, offering dual hormone ...

Boots Online Doctor has revealed the 'very common' side-effects of Mounjaro you need to know about after thousands of people ...

The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and ...

GLP-1 obesity drug use is rising, but long-term adherence remains low. While one-year persistence has improved in 2024, only ...

Investing.com - 在美国糖尿病协会会议上公布的有希望的临床试验结果后，Canaccord Genuity重申了对Fractyl Health Inc (NASDAQ: GUTS )的买入评级和12.00美元的目标价。 该公司分享了其正在进行的Revita手术第3期试验开放标签队列的后续数据，显示13名患者中有12名在停止使用tirzepatide并接受该手术后三个月内保持或减轻了体重 ...

Eli Lilly’s tirzepatide is expected to be worth $62 billion annually by 2030, according to Evaluate. That valuation would be ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...